Pharmacopeia Drug Discovery, Inc. (PCOP)

[surf1944]

7:32AM Pharmacopeia and GlaxoSmithKline collaboration identifies sixth lead compound; receives a $500K milestone payment (PCOP) 1.59 : Co announced that it has identified a new lead for advancement in its alliance with GlaxoSmithKline (GSK), through its collaboration with the Center of Excellence for External Drug Discovery. This newly identified lead compound is from a program being evaluated as a potential treatment for inflammatory pain and is the sixth lead compound identified through the collaboration. As a result of this success, Pharmacopeia received a $500,000 milestone payment from GSK.